Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C: progress and problems

J A Cuthbert1

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas 75235-8887.

Clinical Microbiology Reviews
|October 1, 1994
PubMed
Summary

Hepatitis C virus (HCV) causes liver disease, often becoming chronic. While alpha interferon offers limited treatment, preventing HCV infection is difficult due to viral mutations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis A: old and new.

Clinical microbiology reviews·2001
Same author

Multiple mechanisms, independent of sterol regulatory element binding proteins, regulate low density lipoprotein gene transcription.

Journal of lipid research·2000
Same author

Wilson's disease. Update of a systemic disorder with protean manifestations.

Gastroenterology clinics of North America·1999
Same author

Sterol-independent, sterol response element-dependent, regulation of low density lipoprotein receptor gene expression.

Journal of lipid research·1998
Same author

Overexpression of cholesterol 7alpha-hydroxylase (CYP7A) in mice lacking the low density lipoprotein (LDL) receptor gene. LDL transport and plasma LDL concentrations are reduced.

The Journal of biological chemistry·1998
Same author

Iron, HFE, and hemochromatosis update.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·1998

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) is a primary cause of posttransfusion hepatitis.
  • HCV exhibits significant genetic variability, particularly in hypervariable regions, potentially driven by immune selection.
  • Diagnosis in immunocompetent individuals typically relies on serology, while immunosuppressed patients may require RNA amplification.

Purpose of the Study:

  • To review the characteristics of hepatitis C virus infection.
  • To discuss transmission routes, clinical manifestations, and disease progression.
  • To examine current therapeutic options and challenges in prevention.

Main Methods:

  • Review of existing literature on HCV virology, epidemiology, and clinical outcomes.
  • Analysis of diagnostic approaches for immunocompetent and immunosuppressed populations.
  • Evaluation of treatment efficacy and vaccination challenges.

Main Results:

  • HCV infection frequently leads to chronic carriage with variable hepatocyte damage, fibrosis, cirrhosis, and hepatocellular carcinoma.
  • Disease progression rates vary significantly among individuals.
  • Alpha interferon is the sole available therapy, offering sustained remission in some but with unproven long-term benefits.

Conclusions:

  • HCV infection poses a significant public health challenge due to its chronic nature and variable outcomes.
  • Effective long-term treatments and preventative strategies, including vaccination, are lacking.
  • Understanding the determinants of disease progression is crucial for improving patient management.

Related Experiment Videos